Chinese english Germany Japanese Korea

[2R-[2α,2(S*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-Methoxycyclohexyl)-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-Methyl-2H-pyran-2-yl]acetyl]-

[2R-[2α,2(S*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-Methoxycyclohexyl)-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-Methyl-2H-pyran-2-yl]acetyl]- Struktur
CAS-Nr.
Englisch Name:
[2R-[2α,2(S*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-Methoxycyclohexyl)-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-Methyl-2H-pyran-2-yl]acetyl]-
Synonyma:
(19E/Z)-seco RapaMycin SodiuM Salt, >85% By HPLC;[2R-[2α,2(S*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-Methoxycyclohexyl)-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-Methyl-2H-pyran-2-yl]acetyl]-
CBNumber:
CB32620708
Summenformel:
C51H78NNaO13
Molgewicht:
936.15369
MOL-Datei:
Mol file
Request For Quotation

[2R-[2α,2(S*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-Methoxycyclohexyl)-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-Methyl-2H-pyran-2-yl]acetyl]- Eigenschaften

Sicherheit

[2R-[2α,2(S*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-Methoxycyclohexyl)-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-Methyl-2H-pyran-2-yl]acetyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Yellow Solid

Verwenden

A decomposition product of Rapamycin (R124000).

[2R-[2α,2(S*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-Methoxycyclohexyl)-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-Methyl-2H-pyran-2-yl]acetyl]- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

[2R-[2α,2(S*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-Methoxycyclohexyl)-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-Methyl-2H-pyran-2-yl]acetyl]- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Chemsky（shanghai）International Co.,Ltd. 021-50135380
shchemsky@sina.com China 32344 50
  • (19E/Z)-seco RapaMycin SodiuM Salt, >85% By HPLC
  • [2R-[2α,2(S*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E/Z,21R*,22(1S*,3R*,4R*)]]]-1-[Oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-Methoxycyclohexyl)-2,13-diMethoxy-3,9,11,15,17,21-hexaMethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-Methyl-2H-pyran-2-yl]acetyl]-
Copyright 2019 © ChemicalBook. All rights reserved